Clinical Trials Browser

Phase 2/3 × Recruiting × tebufenozide × Clear all

NCT07084662 2025-11-26

Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma

Phase 2/3 Recruiting

Lymphoma, Large B-Cell, Diffuse